Rapid Nutrition Accelerates China Expansion Amid Booming Health and Wellness Market

With 1600% month-over-month growth in repurchase orders and new KOL partnerships across Douyin and WeChat, Rapid Nutrition accelerates its China expansion strategy

London, United Kingdom – 29 April 2025Rapid Nutrition PLC (Euronext Growth: ALRPD), a leading HealthTech company dedicated to advancing global wellness, today announced strengthened progress in China during March 2025, building momentum in a market forecast to exceed USD 1.65 trillion by 2030.

Following the successful localization of its SystemLS brand and optimized e-commerce strategies, Rapid Nutrition reported a 1600% month-over-month increase in repurchase orders, a major milestone reflecting growing consumer loyalty and brand resonance within China's dynamic health and wellness sector.

China’s health and wellness industry reached USD 774 billion in 2023 and continues to expand rapidly, with overseas supplement brands occupying a significant and growing market share. SystemLS is strategically positioned to capture this demand by offering premium, evidence-based nutrition solutions tailored to the needs of Chinese consumers.

Key operational highlights in March include:

“China represents one of the largest and fastest-growing opportunities globally for wellness brands,” said Simon St. Ledger, CEO of Rapid Nutrition. “Our expanding footprint, enhanced by strategic KOL partnerships and localized innovation, positions Rapid Nutrition to capitalize on the explosive growth in China’s health and wellness sector.”

Rapid Nutrition’s China growth plan targets:

With a foundation built on scientific credibility, premium quality, and localized execution, Rapid Nutrition is poised to accelerate growth across China’s thriving wellness landscape in 2025 and beyond.

About Rapid Nutrition

Rapid Nutrition is a global HealthTech company dedicated to advancing wellness through evidence-based, personalized nutrition solutions. Leveraging advanced technologies, AI, and scientific research, the company is committed to optimizing nutrition, improving health outcomes, and fostering sustainable, healthier lifestyles worldwide.

Investor Relations Contact:

ir@rnplc.com

 

 

 

Disclaimer

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).

Subscribe for Updates